Study on Cannabis Use and Symptom Tracking in Adults with Cancer CURIOUS

What this Trial Is About

This observational study focuses on adults diagnosed with cancer who use cannabis. It aims to improve understanding of symptoms, cannabis use, patient responses to cannabis consumption, and changes in supportive care medications like opioids and antiemetics. The study is designed to collect reliable, cancer-specific data to help patients and their oncology clinicians make informed decisions about incorporating cannabis into treatment plans. Participants will use a secure, app-based technology developed in partnership with Ontracka. After electronically consenting, they will create an account and download the OnTracka mobile app to track their cannabis use and related symptoms. They will complete validated questionnaires, including NCI PRO-CTCAE every two weeks and PROMIS Global along with medication logs every four weeks for the first 12 weeks. Follow-up surveys occur at 6 and 12 months. Throughout the study, researchers will monitor adherence from enrollment to the first 90 days. Participants will provide symptom reports, cannabis use data, and medication changes through the app. This data collection helps assess patient experiences over time. The study participation may last up to one year, with multiple opportunities to report and monitor health status and symptom changes.

Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)